(Q46702750)

24 December 2017

title

Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys (English)

1 reference

24 December 2017

0 references

7

Philippe Birembaut

1 reference

24 December 2017

author name string

Hervé Sartelet

1

1 reference

24 December 2017

Olivier Toupance

2

1 reference

24 December 2017

Marianne Lorenzato

3

1 reference

24 December 2017

Fouad Fadel

4

1 reference

24 December 2017

Laure Hélène Noel

5

1 reference

24 December 2017

Eymeric Lagonotte

6

1 reference

24 December 2017

Jacques Chanard

8

1 reference

24 December 2017

Philippe Rieu

9

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

24 December 2017

American Journal of Transplantation

published in

1 reference

24 December 2017

volume

5

1 reference

24 December 2017

issue

10

1 reference

24 December 2017

page(s)

2441-2447

1 reference

24 December 2017

Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01047.X

Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01047.X

Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01047.X

Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01047.X

Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01047.X

Thrombotic micro-angiopathy with sirolimus-based immunosuppression: potentiation of calcineurin-inhibitor-induced endothelial damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01047.X

Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01047.X

Sirolimus may promote thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01047.X

De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine-sirolimus combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01047.X

Sirolimus-induced thrombotic microangiopathy in a renal transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01047.X

De novo thrombotic microangiopathy following treatment with sirolimus: report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01047.X

Upstream and downstream of mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01047.X

The TOR pathway: a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01047.X

Molecular actions of sirolimus: sirolimus and mTor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01047.X

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01047.X

Vascular endothelial growth factor expression in human chronic renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01047.X

Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01047.X

Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01047.X

10.1111/J.1600-6143.2005.01047.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

16162193

1 reference

24 December 2017